Bevacizumab's Role in Late-Stage Cervical CancerBevacizumab's Role in Late-Stage Cervical Cancer

Dr. Maurie Markman discusses the recent FDA approval of bevacizumab for recurrent or late-stage cervical cancer and weighs the benefits of the drug in this setting against its toxicity profile. Medscape Oncology

Source: Medscape Hematology-Oncology Headlines - September 24, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news